脑部放疗,上午比下午敏感许多!
* x* G: v5 \8 T1 k. E
2 }0 _! y5 A" T! D0 E# s
$ T/ p' x$ X ~' cCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
' o; M! }& E8 H' [% B/ d. T! jGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?3 c& |% Z @& a0 T$ v
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T., f; P' k, e( T- y8 B( ^3 k* _
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
) W2 V. D- }" y; f9 `) v
) R+ ~/ Y- d; d* ^Abstract
. Z# G* d' q. ~7 `3 Y/ oBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
, [2 G% b% Q# ]. Z9 p) S% b
# e9 r) y8 c# [$ y6 Q( e4 z! xMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.& V: i/ j+ k2 Z- a/ a! H3 F1 Z
. n/ N& K* e' n
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
3 B- E9 O$ e* e; q* o
+ y( y9 O; B7 `! l7 X8 |# h; CCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
9 p- K) c- m0 |( B; ~' ~" q, ^
: k: l/ M0 P3 }8 r. ~ |